A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
Status:
Recruiting
Trial end date:
2027-04-30
Target enrollment:
Participant gender:
Summary
The study is designed for multi-center,randomized,double-masked,active-contralled study to
evaluate effective and security of intravitreal injection of IBI302 in subjects with
neovascular age-related macular degeneration.